Skip to content

Author

Ian F. Hermans

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner

Abstract Background Immune checkpoint inhibitor therapy can elicit deep and durable immune responses in patients with cancer, although most do not experience long-term remission. Tumor hypoxia contributes to this treatment failure. We tested whether the clinical-stage hypoxia-activated prodrug tarloxotinib enhances imm...

Zhe Fu, V. Jackson-Patel, K. Farrand et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.